Trading Signals: ADMS Stock Price Prediction and Forecast (Thu. Apr. 10, 2014 - Mon. Aug. 9, 2021)(Adamas Pharmaceuticals Inc)
| ADMS latest price $16.9800 (-5.25%) ($16.9200 - $17.8800) on Mon. Jul. 10, 2017. | |
| | Trend Analysis and Forecast | | | | Average Daily Percentage Swing | 2.22% (three month average) | | RSI | 47 | | Latest Price | $16.9800(-5.25%) | | Stocks Behave Similarly | Similar Stock List | | Daily Trend | ADMS declines -0.6% a day on average for past five trading days. | | Weekly Trend | ADMS advances 1.5% a week on average for past two weeks. | | Market Behavior | Growth stock rally for large cap. Broad based sell-off for small cap. | | Correlated ETFs | Broad market will support ADMS advance at 0% a week (0% probability)
XBI(25%) IBB(22%) XOP(18%) ARKG(17%) IWC(17%) | | Factors Impacting ADMS price | ADMS will decline at least -1.11% in a week (0% probabilities).
VIXM(-11%) UUP(-11%) UNG(-9%) BNDX(-7%) TLT(-5%) | | | | | | | | Relative Volatility | (options are extremely cheap) | | | | | Market Trend Strength | -1.11% (StdDev 2.22%) | | Hourly BBV | 0 () | | Intraday Trend | -5% | | | | | |
|
| Resistance Level | $17.39 | | 5 Day Moving Average | $17.7(-4.07%) | | 10 Day Moving Average | $17.51(-3.03%) | | 20 Day Moving Average | $17.39(-2.36%) | | To recent high | -5.5% | | To recent low | 15.2% | | Market Cap | $480m | | | | | | |
Adamas Pharmaceuticals, Inc. engages in discovery and development of chrono-synchronous therapies for chronic neurologic disorders. Its products include GOCOVRI, ADS-5012, ADS-4101, and Namzaric. GOCOVRI is indicated for the treatment of dyskinesia in patients with Parkinson’s disease receiving levodopa-based therapy. ADS-5102 is a treatment for walking impairment in patients with multiple sclerosis. ADS-401 treats partial onset seizures in patients with epilepsy. Namzaric is a drug treatment for moderate to severe Alzheimer's disease. The company was founded by Gregory T. Went on November 15, 2000 and is headquartered in Emeryville, CA. |